LBF20207PG58

LipidBank Top (トップ)

Fatty acid (脂肪酸)

Glycerolipid (グリセロ脂質)

Sphingolipid (スフィンゴ脂質)

Journals (雑誌一覧)

How to edit (ページの書き方)

Upper classes: LB LBF

IDs and Links
LipidBank	XPR1762
LipidMaps	LMFA03010080
CAS
KEGG	{{{KEGG}}}
KNApSAcK	{{{KNApSAcK}}}
mol	LBF20207PG58

15S-15-methyl Prostaglandin F2α
Structural Information
Systematic Name	(9α,11α,15S) -Trihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-oic acid
Common Name	15S-15-methyl Prostaglandin F2α (9α,11α,15S) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid
Symbol
Formula	C21H36O5
Exact Mass	368.256274262
Average Mass	368.50754
SMILES	C(=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)[C@](C)(O)CCCCC
Physicochemical Information
Melting Point
Boiling Point
Density
Optical Rotation
Refractive Index
Solubility
Source
Chemical Synthesis
Metabolism
Biological Activity	Intramuscularly injection of 15(S)-15-methyl Prostaglandin F2 alpha induce abortion. Lindblom_B et al. 15(S)-15-methyl Prostaglandin F2 alpha causes sustained contractions in human vascular smooth muscle tissues (fetal aorta and arterial smooth muscle from chorionic vessels). Word_RA et al.15(S)-15-methyl Prostaglandin F2 alpha shows reduction of serum progesterone and induction of luteolysis in non-pregnant animal. Wilks_JW
Genetic Information
Note
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

Reported Metabolites, References
Biospecies ID Compound Name Reference Comment n.a. LBF20207PG58 See above. Lindblom_B et al. 1987 n.a. LBF20207PG58 See above. Wilks_JW 1980 n.a. LBF20207PG58 See above. Word_RA et al. 1992